How ACTN2 Affects Your Muscles

While ACTN2-related disease can involve the heart, it is also frequently recognized by how it affects the skeletal muscles—the muscles that allow you to move, breathe, and maintain posture ^[1]. Because the alpha-actinin-2 protein is a structural anchor inside muscle fibers, pathogenic variants in the gene can lead to a variety of “skeletal phenotypes,” or observable patterns of muscle weakness ^[2][3].

Doctors and researchers currently categorize these manifestations into several distinct groups based on limited reported cohorts. Your presentation does not have to perfectly match one typical pattern.

Congenital-Onset (Early) Myopathy

In some cases, muscle weakness is present from birth or early infancy. In limited reports, some of these have been de novo cases, meaning the genetic change happened for the first time in the child and was not inherited from a parent ^[2].

• Progressive Weakness: Unlike some other congenital conditions that stay stable, the weakness in ACTN2 congenital myopathy can be progressive, meaning it may become more pronounced over time ^[2].
• Respiratory Involvement: A key feature of the congenital form is the potential for breathing difficulties. Some children may require breathing support because the muscles used for breathing are weakened ^[2]. This neuromuscular hypoventilation typically requires bilevel non-invasive ventilation (like a BiPAP machine), whereas a CPAP is generally used for coexisting obstructive sleep apnea.

Adult-Onset Dominant Myopathy

For many individuals, symptoms do not appear until adulthood. This pattern has been reported in the autosomal dominant form of the disease ^[1].

• The Asymptomatic Range: Some people with a pathogenic ACTN2 variant may not have noticeable symptoms, or only develop them later in life (reduced penetrance) ^[1].
• Limb-Girdle, Distal, and Facial Weakness: When symptoms do occur, they often involve the proximal muscles (hips and shoulders) in a limb-girdle pattern, or the distal muscles (hands and feet) ^[1][3]. Some patients also experience weakness in the facial muscles or the muscles that lift the eyelids ^[1].

Biallelic (Recessive) Myopathy

A specific group of patients has been identified with a “biallelic” or recessive pattern, meaning they inherited two pathogenic copies of a specific ACTN2 variant (p.Arg506Gly) ^[4].

• Asymmetric Lower-Limb Weakness: This group tends to experience progressive weakness that starts in the legs. Interestingly, this weakness is often asymmetric, meaning one leg may be significantly weaker than the other ^[4].
• Distinct Sparing: In the small number of cases reported so far, these individuals did not have heart issues (cardiomyopathy) or respiratory problems ^[4]. However, because this is an observation from a limited cohort, the absence of reported complications does not guarantee that those systems are completely safe. Individualized screening is still required.

Understanding the Muscle Biopsy

If you or your child had a muscle biopsy, the pathology report might use terms like actininopathy or core myopathy.

• Structured Cores and Multiminicores: These terms refer to microscopic regions within the muscle fibers where the normal sarcomere organization is altered ^[2][3].
  • Structured cores often show jagged “Z-lines” (the anchors of the muscle) ^[2].
  • Multiminicores are smaller, scattered areas of altered organization ^[3].

These “cores” are a descriptive pathology pattern. They are not specific, required proof of ACTN2 disease by themselves. A compatible pathogenic genetic result often avoids the need for a biopsy entirely. When performed, the biopsy provides one piece of supportive evidence, but the most important part of care remains managing your physical symptoms ^[1][2].